SCIENION AG and RareCyte Inc. today announced that cellenONE® proved to be a most appropriate device for accurate single-cell dispensing of low numbers of model circulating tumor cells (CTCs) in oncology applications. RareCyte uses the versatile technology of SCIENION’s French subsidiary Cellenion for precise and reproducible dosing of a predefined number of targeted CTCs into […]
continue readingSCIENION and Randox expand collaboration to transform high throughput biochip manufacturing
Multiyear alliance underpins Randox commitment to increase biochip manufacturing to transform rapid diagnostic testing SCIENION AG to integrate its precision dispensing technology to enable Randox to scale-up Biochip manufacturing across the business Joint activities will include co-working at Randox, Crumlin (Northern Ireland), Randox, Dungloe (Republic of Ireland), and at SCIENION AG headquarters in Berlin (Germany) […]
continue readingSCIENION und Randox bauen Zusammenarbeit aus, um die High Throughput Produktion von Biochips zu transformieren
Mehrjährige Allianz unterstreicht Randox Engagement die Biochip-Produktion zu erhöhen, um diagnostische Schnelltests voranzubringen SCIENION AG integriert seine präzise Dispensiertechnologie, um es Randox zu ermöglichen, Produktionskapazitäten in allen Geschäftsbereichen zu erhöhen Gemeinsame Aktivitäten beinhalten die Zusammenarbeit an den Randox-Standorten Crumlin (Nordirland), Dungloe (Republik Irland) und am Unternehmenssitz von SCIENION in Berlin – inklusive einer massiven Erhöhung […]
continue reading